452 related articles for article (PubMed ID: 22927184)
1. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency.
George JN; Chen Q; Deford CC; Al-Nouri Z
J Clin Apher; 2012; 27(6):302-11. PubMed ID: 22927184
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
Shenkman B; Einav Y
Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children.
Loirat C; Veyradier A; Girma JP; Ribba AS; Meyer D
Semin Thromb Hemost; 2006 Mar; 32(2):90-7. PubMed ID: 16575683
[TBL] [Abstract][Full Text] [Related]
7. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features.
Reese JA; Muthurajah DS; Kremer Hovinga JA; Vesely SK; Terrell DR; George JN
Pediatr Blood Cancer; 2013 Oct; 60(10):1676-82. PubMed ID: 23729372
[TBL] [Abstract][Full Text] [Related]
8. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
Yagi H; Matsumoto M; Fujimura Y
Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
[TBL] [Abstract][Full Text] [Related]
9. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes.
George JN; Al-Nouri ZL
Hematology Am Soc Hematol Educ Program; 2012; 2012():604-9. PubMed ID: 23233641
[TBL] [Abstract][Full Text] [Related]
11. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989-2007.
George JN
Kidney Int Suppl; 2009 Feb; (112):S52-4. PubMed ID: 19180137
[TBL] [Abstract][Full Text] [Related]
12. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura.
Edgar CE; Terrell DR; Vesely SK; Wren JD; Dozmorov IM; Niewold TB; Brown M; Zhou F; Frank MB; Merrill JT; Kremer Hovinga JA; Lämmle B; James JA; George JN; Farris AD
PLoS One; 2015; 10(2):e0117614. PubMed ID: 25671313
[TBL] [Abstract][Full Text] [Related]
13. Congenital ADAMTS13 deficiency: a rare mimicker of immune thrombocytopenic purpura.
Quintero V; Garcia-Pose A; Barrios-Tascon A; Pacheco-Cumani M
J Pediatr Hematol Oncol; 2014 Nov; 36(8):653-5. PubMed ID: 24942015
[TBL] [Abstract][Full Text] [Related]
14. ADAMTS-13 assays in thrombotic thrombocytopenic purpura.
Peyvandi F; Palla R; Lotta LA; Mackie I; Scully MA; Machin SJ
J Thromb Haemost; 2010 Apr; 8(4):631-40. PubMed ID: 20088924
[TBL] [Abstract][Full Text] [Related]
15. Low incidence of ADAMTS13 missense mutation R1060W in adult Egyptian patients with thrombotic thrombocytopenic purpura.
El Sissy MH; El Hafez AA; El Sissy AH
Acta Haematol; 2014; 132(1):30-5. PubMed ID: 24401653
[TBL] [Abstract][Full Text] [Related]
16. TTP and ADAMTS13: When Is Testing Appropriate?
Mannucci PM; Peyvandi F
Hematology Am Soc Hematol Educ Program; 2007; ():121-6. PubMed ID: 18024619
[TBL] [Abstract][Full Text] [Related]
17. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
18. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
[TBL] [Abstract][Full Text] [Related]
19. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic thrombocytopenic purpura: a moving target.
Sadler JE
Hematology Am Soc Hematol Educ Program; 2006; ():415-20. PubMed ID: 17124092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
